Breaking News Instant updates and real-time market news.

RHHBY

Roche

$31.72

-0.27 (-0.84%)

11:35
10/06/17
10/06
11:35
10/06/17
11:35

Roche receives FDA approval for cobas Zika test

Roche announced that it has received approval from the U.S. Food and Drug Administration for the cobas Zika test for use on the cobas 6800/8800 Systems.The cobas Zika test is the first commercially available test for the detection of the Zika virus RNA in samples of human plasma intended for use in screening blood donations.The newly approved cobas Zika test can now be used alongside other routine tests for the screening of blood and plasma donations in the U.S. Roche deployed the cobas Zika test in April of 2016 under the FDA's IND Protocol to screen blood donations collected in Puerto Rico. This initial testing protocol enabled the reinstatement of the blood services in Puerto Rico after concerns over the high rates of infection locally posed a significant threat to the blood supply. By the end of 2016, expanded deployment for the cobas Zika test supported donor screening efforts throughout the U.S. and Puerto Rico. Reference Link

  • 06

    Nov

  • 30

    Nov

RHHBY Roche
$31.72

-0.27 (-0.84%)

08/23/17
WBLR
08/23/17
INITIATION
Target $107
WBLR
Outperform
AveXis initiated with an Outperform at William Blair
William Blair analyst Raju Prasad started AveXis (AVXS) with an Outperform rating and $107 fair value estimate, noting that the company's Phase I data for AVXS-101have continued to show a meaningful benefit in spinal muscular atrophy type 1. The analyst, who thinks AveXis has a high probability of receiving guidance for a potential regulatory filing following the company's end-of-Phase I meeting with the FDA, said AveXis could become an acquisition target within the next 12-18 months. If so, an acquisition price could be in the range of $150-$160 per share, with Roche (RHHBY) and Biogen (BIIB) possible suitors, Prasad tells investors.
09/12/17
MAXM
09/12/17
NO CHANGE
MAXM
Inovio data positive, says Maxim
Maxim analyst Jason McCarthy says that the data on Inovio's (INO) INO-5150 for prostate cancer indicates that the drug "holds promise." He thinks that the company may find a new partner to replace Roche (RHHBY), and he keeps a $12 price target and a Buy rating on the shares.
09/12/17
COWN
09/12/17
NO CHANGE
COWN
Cowen says cervical cancer recommendations a risk for Hologic, Becton Dickinson
Cowen analyst Doug Schenkel noted that the US Preventive Services Task Force recently released a draft recommendation on cervical cancer screening, which no longer recommends cotesting with both an HPV assay and cytology, which would be a negative for Hologic (HOLX) and Becton Dickinson (BDX) if the draft is implemented. If the draft is implemented, it is likely a positive for Roche (RHHBY), the only vendor with a primary screening HPV assay that is FDA approved, added Schenkel. However, the final recommendation statement can be materially different from the draft, he said.
09/21/17
JEFF
09/21/17
NO CHANGE
JEFF
Buy
Jefferies sees Roche's 'TOGA Party' assets driving upside to estimates
Jefferies analyst Jeffrey Holford says Roche's new product launches and indications are being underestimated by investors as fear of biosimilars dominates. The analyst believes Tecentriq, Ocrevus, Gazyva, ACE910 and Perjeta, what he calls the "TOGA Party" assets, will drive "significant revenue growth" and upside relative to consensus. Biosimilars are coming, but Roche can still post mid-to-high single digit annual earnings growth, Holford tells investors in a research note titled "TOGA Party: Opportunity In The Face Of Adversity." He raised his price target for the shares to CHF 290 from CHF 175 and keeps a Buy rating on the name. Holford also highlights the potential for special dividends and accretive acquisitions as Roche's cash continues to build and it meets its net debt target.

TODAY'S FREE FLY STORIES

WHR

Whirlpool

$182.10

-0.36 (-0.20%)

11:31
10/23/17
10/23
11:31
10/23/17
11:31
Technical Analysis
Technical Earnings Preview: Whirlpool has a potential bullish pattern »

On the daily chart there…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 14

    Nov

EBAY

eBay

$37.61

0.32 (0.86%)

, PYPL

PayPal

$70.97

3.72 (5.53%)

11:30
10/23/17
10/23
11:30
10/23/17
11:30
Recommendations
eBay, PayPal analyst commentary  »

NFL deal highlights value…

EBAY

eBay

$37.61

0.32 (0.86%)

PYPL

PayPal

$70.97

3.72 (5.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

NFLX

Netflix

$194.16

-0.97 (-0.50%)

11:30
10/23/17
10/23
11:30
10/23/17
11:30
Options
Size call condor in Netflix rerolls position from last week »

Size call condor in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$22.57

-1.26 (-5.29%)

11:29
10/23/17
10/23
11:29
10/23/17
11:29
Hot Stocks
Battleground: Analysts diverge on General Electric earnings power »

This morning, Bank of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$62.92

1.16 (1.88%)

, GOOG

Alphabet

$988.20

3.75 (0.38%)

11:20
10/23/17
10/23
11:20
10/23/17
11:20
Hot Stocks
Target climbs as retailer gears up for crucial holiday season »

EXCLUSIVE BRANDS: After…

TGT

Target

$62.92

1.16 (1.88%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

WMT

Wal-Mart

$88.24

0.8 (0.91%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 16

    Nov

  • 21

    Nov

  • 29

    Nov

  • 20

    Feb

  • 18

    Mar

XLF

Financial Select Sector

$26.67

0.025 (0.09%)

11:20
10/23/17
10/23
11:20
10/23/17
11:20
Options
Notable option play in SPDR Financial ETF Monday morning »

Notable option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:20
10/23/17
10/23
11:20
10/23/17
11:20
General news
Treasury announced a $45 B 4-week bill auction for Tuesday »

Treasury announced a $45…

$NSD

NASDAQ Market Internals

11:17
10/23/17
10/23
11:17
10/23/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
10/23/17
10/23
11:16
10/23/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PANW

Palo Alto Networks

$146.80

-2.81 (-1.88%)

11:15
10/23/17
10/23
11:15
10/23/17
11:15
Options
Palo Alto Networks put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

  • 11

    Dec

11:15
10/23/17
10/23
11:15
10/23/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
10/23/17
10/23
11:15
10/23/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

SINA

Sina

$110.48

-1.12 (-1.00%)

11:14
10/23/17
10/23
11:14
10/23/17
11:14
Hot Stocks
Aristeia says Glass Lewis endorses nominees for Sina board »

Aristeia Capital, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Nov

JNJ

Johnson & Johnson

$143.95

1.5514 (1.09%)

11:13
10/23/17
10/23
11:13
10/23/17
11:13
Conference/Events
Johnson & Johnson management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

SNY

Sanofi

$49.59

0.075 (0.15%)

, TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

11:11
10/23/17
10/23
11:11
10/23/17
11:11
Conference/Events
Worldwide Business Research to hold a summit »

BioNetwork Partnering…

SNY

Sanofi

$49.59

0.075 (0.15%)

TKPYY

Takeda Pharmaceutical Co. Ltd.

$28.07

-0.15 (-0.53%)

UNH

UnitedHealth

$207.31

-0.18 (-0.09%)

NVS

Novartis

$86.54

0.8 (0.93%)

HZNP

Horizon Pharma

$14.09

-0.05 (-0.35%)

ABBV

AbbVie

$95.55

-0.55 (-0.57%)

BAYRY

Bayer

$34.80

-0.41 (-1.16%)

MRK

Merck

$64.37

0.49 (0.77%)

RDHL

RedHill Biopharma

$9.25

0.47 (5.35%)

NBRV

Nabriva Therapeutics

$6.33

-0.31 (-4.67%)

PFE

Pfizer

$36.68

0.26 (0.71%)

TEVA

Teva

$14.70

-0.2 (-1.34%)

GILD

Gilead

$81.21

-0.38 (-0.47%)

ALXN

Alexion

$139.02

-1.44 (-1.03%)

GSK

GlaxoSmithKline

$40.76

-0.085 (-0.21%)

REGN

Regeneron

$432.98

-7.96 (-1.81%)

CELG

Celgene

$121.33

-14.63 (-10.76%)

LLY

Eli Lilly

$87.85

0.62 (0.71%)

AMGN

Amgen

$182.96

-1.16 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 27

    Oct

  • 27

    Oct

  • 28

    Oct

  • 31

    Oct

  • 02

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 13

    Nov

  • 16

    Nov

  • 16

    Nov

  • 30

    Nov

  • 30

    Nov

  • 02

    Dec

  • 04

    Dec

  • 02

    Feb

  • 03

    Feb

  • 12

    Feb

  • 30

    Apr

  • 17

    May

  • 28

    May

CUB

Cubic

$54.75

1.7 (3.20%)

11:10
10/23/17
10/23
11:10
10/23/17
11:10
Periodicals
MTA ready to roll out new payment system built by Cubic, NY Post reports »

The MTA is ready to roll…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:07
10/23/17
10/23
11:07
10/23/17
11:07
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

NTNX

Nutanix

$26.67

0.33 (1.25%)

11:05
10/23/17
10/23
11:05
10/23/17
11:05
Options
Nutanix call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
10/23/17
10/23
11:05
10/23/17
11:05
General news
Euro$ interest rate futures are relatively steady »

Euro$ interest rate…

OPGN

OpGen

$0.37

-0.0014 (-0.38%)

11:01
10/23/17
10/23
11:01
10/23/17
11:01
Hot Stocks
OpGen announces award of $860K CDC contract »

OpGen announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETS

PetMed Express

$36.74

0.87 (2.43%)

11:00
10/23/17
10/23
11:00
10/23/17
11:00
Recommendations
PetMed Express analyst commentary  »

PetMed Express target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 06

    Nov

EGO

Eldorado Gold

$1.79

-0.38 (-17.51%)

10:57
10/23/17
10/23
10:57
10/23/17
10:57
Downgrade
Eldorado Gold rating change  »

Eldorado Gold downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

, S

Sprint

$6.99

0.055 (0.79%)

10:55
10/23/17
10/23
10:55
10/23/17
10:55
Hot Stocks
T-Mobile adds 1.3M customers as Un-carrier remains mum on potential Sprint deal »

Shares of T-Mobile US…

TMUS

T-Mobile

$60.46

-1.05 (-1.71%)

S

Sprint

$6.99

0.055 (0.79%)

DTEGY

Deutsche Telekom

$18.06

-0.09 (-0.50%)

SFTBF

SoftBank

$88.50

1.25 (1.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 01

    Nov

  • 07

    Nov

  • 07

    Nov

  • 16

    May

HAS

Hasbro

$98.19

1.52 (1.57%)

10:55
10/23/17
10/23
10:55
10/23/17
10:55
Options
Hasbro put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

NWBI

Northwest Bancshares

$17.66

0.08 (0.46%)

10:52
10/23/17
10/23
10:52
10/23/17
10:52
Earnings
Northwest Bancshares reports Q3 EPS 24c, consensus 22c »

Net interest income…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.